Tinker, Am I mistaken? If a clinical trial was required for generic copaxone, wouldn't the FDA just be looking for safety profile. If so, wouldn't they be able to show safety with a smaller group in a year or so?
I believe that by law the FDA can not request a trial for safety/efficacy on an ANDA.
That is actually the basis of the SA suit against the FDA on mL, they are claiming that the immune. data request is actually a safety trial and thus is against the law (and subsequently makes the FDA's use of SA data illegal).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.